{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:32:54Z","timestamp":1777883574304,"version":"3.51.4"},"reference-count":26,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Addiction Journal"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Inhalants are a very diverse class of substances with a highly prevalent recreational use. Difluroethane (DFE) is a psychoactive ingredient present in several propellants and dust remover products. Past reports have described the toxicological effects of this compound, but its addictive potential is poorly described in the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case:<\/jats:title>\n                    <jats:p>We present a case report (N\u2009=\u20091) of an adult man who very rapidly developed a severe inhalant use disorder (IUD), in the context of an early remission of an alcohol use disorder (AUD). He received treatment with naltrexone in a residential treatment program. He provided verbal and written consent for the publication of this case report.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>This is the first follow-up case of dust remover-IUD treated with naltrexone described in the literature. This case is clinically important for several reasons, including its atypical age of presentation, rapid progression, medical consequences, and positive response to multimodal treatment. The easy availability and lack of regulation of many inhalants, such as DFE, combined with the inability to be detected in regular screening tests, make this phenomenon a potential public health threat. We hypothesize that, consistent with previous reports, there might be a common neurobiological signature between AUD and IUD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/29767342241297436","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T06:57:00Z","timestamp":1750143420000},"page":"718-721","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Dust Remover Inhalant Use Disorder in an Individual in Early Remission from Alcohol Use Disorder Treated with Naltrexone"],"prefix":"10.1177","volume":"46","author":[{"given":"India A.","family":"Reddy","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Utah, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-0939","authenticated-orcid":false,"given":"Javier","family":"Ballester","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Utah, Salt Lake City, UT, USA"},{"name":"Department of Psychiatry, VA Salt Lake City Health Care System, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"issue":"1","key":"e_1_3_2_2_2","first-page":"18","article-title":"Inhalant use and inhalant use disorders in the United States","volume":"6","author":"Howard MO","year":"2011","unstructured":"Howard MO, Bowen SE, Garland EL, Perron BE, Vaughn MG. Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract. 2011;6(1):18-31.","journal-title":"Addict Sci Clin Pract"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2019.1657880"},{"key":"e_1_3_2_4_2","unstructured":"CPSC.gov. Staff Briefing Package\u2014Aerosol Dusters. United States Consumer Product Safety Commission. Accessed May 18 2023. https:\/\/www.cpsc.gov\/s3fs-public\/Petition-Requesting-Rulemaking-to-Establish-Safety-Standard.pdf"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4627890"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2022.2027207"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1081\/clt-100102469"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2923"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.paf.0000202715.71009.0e"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-14-4919"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.8.638"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkab054"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5565"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2010.08.026"},{"key":"e_1_3_2_15_2","first-page":"1","volume-title":"Tasman\u2019s Psychiatry","author":"Salloum IM","unstructured":"Salloum IM, Stewart CM, Abou-Saleh MT. Disorders due to substance use: inhalants. In: Tasman A, Riba MB, Alarc\u00f3n RD, et al. (eds) Tasman\u2019s Psychiatry. Springer International Publishing; 2023:1-41."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.etdah.2021.100006"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADT.0b013e3182645566"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0376-8716(98)00078-7"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa272"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(24)23230-2"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703666"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000642"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abrep.2022.100406"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1319-4"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/13556210020040190"},{"key":"e_1_3_2_26_2","unstructured":"Substance Abuse and Mental Health Services Administration. (2022). Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22-07-01-005 NSDUH Series H-57). Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration. https:\/\/www.samhsa.gov\/data\/report\/2021-nsduh-annual-national-report"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.10.017"}],"container-title":["Substance Use &amp; Addiction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342241297436","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29767342241297436","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342241297436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:50:37Z","timestamp":1777600237000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29767342241297436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1177\/29767342241297436"],"URL":"https:\/\/doi.org\/10.1177\/29767342241297436","relation":{},"ISSN":["2976-7342","2976-7350"],"issn-type":[{"value":"2976-7342","type":"print"},{"value":"2976-7350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}